Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2.

Blum K, Chen TJ, Morse S, Giordano J, Chen AL, Thompson J, Allen C, Smolen A, Lubar J, Stice E, Downs BW, Waite RL, Madigan MA, Kerner M, Fornari F, Braverman ER.

Postgrad Med. 2010 Nov;122(6):214-26. doi: 10.3810/pgm.2010.11.2237.

PMID:
21084796
2.

Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports.

Miller DK, Bowirrat A, Manka M, Miller M, Stokes S, Manka D, Allen C, Gant C, Downs BW, Smolen A, Stevens E, Yeldandi S, Blum K.

Postgrad Med. 2010 Nov;122(6):188-213. doi: 10.3810/pgm.2010.11.2236. Review.

PMID:
21084795
3.

Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).

Blum K, Chen TJ, Downs BW, Bowirrat A, Waite RL, Braverman ER, Madigan M, Oscar-Berman M, DiNubile N, Stice E, Giordano J, Morse S, Gold M.

Postgrad Med. 2009 Nov;121(6):176-96. doi: 10.3810/pgm.2009.11.2087. Review.

4.
5.

Reward deficiency syndrome: genetic aspects of behavioral disorders.

Comings DE, Blum K.

Prog Brain Res. 2000;126:325-41. Review.

PMID:
11105655
6.
7.

Relationship between dopaminergic neurotransmission, alcoholism, and Reward Deficiency syndrome.

Bowirrat A, Oscar-Berman M.

Am J Med Genet B Neuropsychiatr Genet. 2005 Jan 5;132B(1):29-37. Review.

PMID:
15457501
8.

[Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].

Auxéméry Y.

Encephale. 2012 Oct;38(5):373-80. doi: 10.1016/j.encep.2011.12.003. Epub 2012 Jan 24. Review. French.

PMID:
23062450
9.

Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary.

Blum K, Chen AL, Chen TJ, Braverman ER, Reinking J, Blum SH, Cassel K, Downs BW, Waite RL, Williams L, Prihoda TJ, Kerner MM, Palomo T, Comings DE, Tung H, Rhoades P, Oscar-Berman M.

Theor Biol Med Model. 2008 Nov 12;5:24. doi: 10.1186/1742-4682-5-24. Review.

10.

D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes.

Noble EP.

Am J Med Genet B Neuropsychiatr Genet. 2003 Jan 1;116B(1):103-25. Review.

PMID:
12497624
11.

A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry.

Gold MS, Badgaiyan RD, Blum K.

Psychiatr Clin North Am. 2015 Sep;38(3):419-62. doi: 10.1016/j.psc.2015.05.011. Review.

PMID:
26300032
12.

The DRD2 gene in psychiatric and neurological disorders and its phenotypes.

Noble EP.

Pharmacogenomics. 2000 Aug;1(3):309-33. Review.

PMID:
11256581
13.

Pharmacogenetics of D2 dopamine receptor gene in prolactin-secreting pituitary adenomas.

Filopanti M, Lania AG, Spada A.

Expert Opin Drug Metab Toxicol. 2010 Jan;6(1):43-53. doi: 10.1517/17425250903352501. Review.

PMID:
19929252
14.

Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors.

Blum K, Braverman ER, Holder JM, Lubar JF, Monastra VJ, Miller D, Lubar JO, Chen TJ, Comings DE.

J Psychoactive Drugs. 2000 Nov;32 Suppl:i-iv, 1-112. Review.

PMID:
11280926
15.

Substance abuse vulnerability and D2 receptor genes.

Uhl G, Blum K, Noble E, Smith S.

Trends Neurosci. 1993 Mar;16(3):83-8. Review.

PMID:
7681236
16.

The D2 dopamine receptor gene as a determinant of reward deficiency syndrome.

Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Cull JG, Comings DE.

J R Soc Med. 1996 Jul;89(7):396-400. Review.

17.
18.

Drug addiction. Part II. Neurobiology of addiction.

Vetulani J.

Pol J Pharmacol. 2001 Jul-Aug;53(4):303-17. Review.

19.

The addictive brain: all roads lead to dopamine.

Blum K, Chen AL, Giordano J, Borsten J, Chen TJ, Hauser M, Simpatico T, Femino J, Braverman ER, Barh D.

J Psychoactive Drugs. 2012 Apr-Jun;44(2):134-43. Review.

PMID:
22880541
20.

Imaging genetics and the neurobiological basis of individual differences in vulnerability to addiction.

Sweitzer MM, Donny EC, Hariri AR.

Drug Alcohol Depend. 2012 Jun;123 Suppl 1:S59-71. doi: 10.1016/j.drugalcdep.2012.01.017. Epub 2012 Feb 16. Review.

Supplemental Content

Support Center